Terms: = Colorectal cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809
1219 results:
1. Exploring the Key Signaling Pathways and ncRNAs in colorectal cancer.
Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
[TBL] [Abstract] [Full Text] [Related]
2. SF3B3-regulated mtor alternative splicing promotes colorectal cancer progression and metastasis.
Xu T; Li X; Zhao W; Wang X; Jin L; Feng Z; Li H; Zhang M; Tian Y; Hu G; Yue Y; Dai X; Shan C; Zhang W; Zhang C; Zhang Y
J Exp Clin Cancer Res; 2024 Apr; 43(1):126. PubMed ID: 38671459
[TBL] [Abstract] [Full Text] [Related]
3. Ginsenoside Rg1 Induces Autophagy in colorectal cancer through Inhibition of the Akt/mtor/p70S6K Pathway.
Liu R; Zhang B; Zou S; Cui L; Lin L; Li L
J Microbiol Biotechnol; 2024 Apr; 34(4):774-782. PubMed ID: 38668684
[TBL] [Abstract] [Full Text] [Related]
4. PI3K/Akt/mtor Signaling Pathway as a Target for colorectal cancer Treatment.
Leiphrakpam PD; Are C
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542151
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
Egusquiza-Alvarez CA; Moreno-Londoño AP; Alvarado-Ortiz E; Ramos-Godínez MDP; Sarabia-Sánchez MA; Castañeda-Patlán MC; Robles-Flores M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473963
[TBL] [Abstract] [Full Text] [Related]
6. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mtor signaling pathway].
Tao SN; Liu XC; Wang YY; Yang H
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
[No Abstract] [Full Text] [Related]
7. Broccoli extracellular vesicles enhance the therapeutic effects and restore the chemosensitivity of 5-fluorouracil on colon cancer.
Cao Y; Hou L; Li M; Zhang J; Wang L; Liu C; Luo T; Yan L; Zheng L
Food Chem Toxicol; 2024 Apr; 186():114563. PubMed ID: 38442787
[TBL] [Abstract] [Full Text] [Related]
8. Pyrvinium Pamoate Induces Cell Apoptosis and Autophagy in colorectal cancer.
Zheng W; Chen K; Lv Y; Lao W; Zhu H
Anticancer Res; 2024 Mar; 44(3):1193-1199. PubMed ID: 38423653
[TBL] [Abstract] [Full Text] [Related]
9. Selective Synergy of Rapamycin Combined With Methioninase on cancer Cells Compared to Normal Cells.
Ardjmand D; Kubota Y; Sato M; Han Q; Mizuta K; Morinaga S; Hoffman RM
Anticancer Res; 2024 Mar; 44(3):929-933. PubMed ID: 38423628
[TBL] [Abstract] [Full Text] [Related]
10. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
11. TMEM97 knockdown inhibits 5-fluorouracil resistance by regulating epithelial-mesenchymal transition and ABC transporter expression via inactivating the Akt/mtor pathway in 5-fluorouracil-resistant colorectal cancer cells.
Xu Y; Tang Y; Xu Q; He W
Chem Biol Drug Des; 2024 Feb; 103(2):e14490. PubMed ID: 38388887
[TBL] [Abstract] [Full Text] [Related]
12. The pathogenicity of vancomycin-resistant Enterococcus faecalis to colon cancer cells.
Zhang L; Deng M; Liu J; Zhang J; Wang F; Yu W
BMC Infect Dis; 2024 Feb; 24(1):230. PubMed ID: 38378500
[TBL] [Abstract] [Full Text] [Related]
13. A free fatty acid receptor agonist inducing autophagy in HT-29 cells by downregulating the AKT/mtor signaling pathway.
Hoveizi E; Rafienia B; Shahriari A
J Cancer Res Ther; 2023 Oct; 19(7):1931-1938. PubMed ID: 38376299
[TBL] [Abstract] [Full Text] [Related]
14. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mtor pathway and is a therapeutic target.
Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
[TBL] [Abstract] [Full Text] [Related]
15. Everolimus exerts anticancer effects through inhibiting the interaction of matrix metalloproteinase-7 with syndecan-2 in colon cancer cells.
Lee S; Jang B; Hwang J; Lee Y; Cho S; Yang H; Yun JH; Shin DH; Lee W; Oh ES
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1067-C1079. PubMed ID: 38314724
[TBL] [Abstract] [Full Text] [Related]
16. Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.
Yang H; Xiao X; Zeng L; Zeng H; Zheng Y; Wang J; Li G; Dai W; He Y; Wang S; Peng J; Chen W
J Transl Med; 2024 Feb; 22(1):132. PubMed ID: 38310289
[TBL] [Abstract] [Full Text] [Related]
17. Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs.
Abd El-Hafeez T; Shams MY; Elshaier YAMM; Farghaly HM; Hassanien AE
Sci Rep; 2024 Jan; 14(1):2428. PubMed ID: 38287066
[TBL] [Abstract] [Full Text] [Related]
18. In vitro and in vivo anti-colorectal cancer effect of the newly synthesized sericin/propolis/fluorouracil nanoplatform through modulation of PI3K/AKT/mtor pathway.
Diab SE; Tayea NA; Elwakil BH; Elshewemi SS; Gad AAEM; Abdulmalek SA; Ghareeb DA; Olama ZA
Sci Rep; 2024 Jan; 14(1):2433. PubMed ID: 38286826
[TBL] [Abstract] [Full Text] [Related]
19. Deletion of IL-27p28 induces CD8 T cell immunity against colorectal tumorigenesis.
Li P; Pu S; Yi J; Li X; Wu Q; Yang C; Kang M; Peng F; Zhou Z
Int Immunopharmacol; 2024 Feb; 128():111464. PubMed ID: 38224627
[TBL] [Abstract] [Full Text] [Related]
20. Roles of Rictor alterations in gastrointestinal tumors (Review).
Cao R; Guo S; Min L; Li P
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186315
[TBL] [Abstract] [Full Text] [Related]
[Next]
